INFLAMMATION

Overview

Inflammation is a fundamental biological response of the immune system to harmful stimuli, including pathogens, damaged cells, and irritants. This complex physiological process serves as a critical defense mechanism, attempting to remove the initial cause of cell injury, clear out necrotic cells and tissues, and initiate tissue repair. While acute inflammation represents a protective and typically self-limiting response, chronic inflammation persists over extended periods and becomes a driver of pathology in numerous diseases, including neurodegenerative disorders.

In the context of neurodegeneration research, neuroinflammation refers specifically to inflammation occurring within the central nervous system (CNS). This process involves the activation of resident immune cells, particularly microglia and astrocytes, along with the recruitment of peripheral immune cells when blood-brain barrier integrity is compromised. Neuroinflammation has emerged as a pivotal phenomenon in the pathogenesis of Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), and frontotemporal dementia (FTD). The bidirectional relationship between neuroinflammation and protein aggregation—where inflammatory processes contribute to neurodegeneration while misfolded proteins themselves trigger inflammatory responses—has positioned inflammation as both a therapeutic target and a biomarker of disease progression.

Function/Biology

Under normal physiological conditions, the inflammatory response is tightly regulated through a balance of pro-inflammatory and anti-inflammatory signals. The canonical inflammatory cascade begins with pattern recognition receptors (PRRs) on immune cells detecting pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs). In the brain, microglia express receptors including TLR4 (Toll-like receptor 4) and TLR2, which recognize both microbial components and endogenous danger signals released from damaged neurons.

Following receptor activation, intracellular signaling pathways including NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) and MAPK (mitogen-activated protein kinase) cascades are triggered, leading to the transcription of inflammatory genes. The downstream effects include production of pro-inflammatory cytokines such as IL-1β (interleukin-1 beta), IL-6 (interleukin-6), and TNF-α (tumor necrosis factor alpha). Additionally, cyclooxygenase enzymes (COX-1, COX-2) produce prostaglandins, while inducible nitric oxide synthase (iNOS/NOS2) generates nitric oxide—all contributing to the inflammatory milieu.

A critical regulatory mechanism involves the NLRP3 inflammasome, a multiprotein complex that activates caspase-1, which in turn cleaves pro-IL-1β and pro-IL-18 into their active secreted forms. The NRF2 (nuclear factor erythroid 2-related factor 2) pathway represents a counter-regulatory system, activating expression of antioxidant and anti-inflammatory genes through the KEAP1-NRF2 axis. This pathway helps resolve inflammation by promoting the production of protective proteins including heme oxygenase-1 (HO-1) and NAD(P)H quinone dehydrogenase 1 (NQO1).

Role in Neurodegeneration

Neuroinflammation plays a dual role in neurodegeneration—both as a consequence of protein aggregation and as an active contributor to disease progression. In Alzheimer’s disease, β-amyloid plaques directly activate microglia through TLR receptors, triggering chronic inflammation that fails to clear deposits effectively and instead contributes to neuronal dysfunction. Activated microglia surround amyloid plaques in characteristic patterns, releasing neurotoxic cytokines that exacerbate synaptic loss and cognitive decline. Similarly, hyperphosphorylated tau protein activates inflammatory pathways, creating a self-perpetuating cycle of aggregation and inflammation.

In Parkinson’s disease, α-synuclein aggregates activate microglia via TLR signaling, leading to chronic production of IL-1β, TNF-α, and reactive oxygen species (ROS) that damage dopaminergic neurons in the substantia nigra pars compacta. Post-mortem studies consistently demonstrate elevated inflammatory markers in PD brains, and epidemiological data suggests that chronic NSAID use correlates with reduced PD risk.

ALS pathology involves motor neuron death accompanied by robust microglial activation, with mutant SOD1 (superoxide dismutase 1) aggregates triggering inflammatory responses that accelerate disease progression in animal models. In Huntington’s

Pathway Diagram

The following diagram shows the key molecular relationships involving INFLAMMATION discovered through SciDEX knowledge graph analysis:

graph TD
    TNF["TNF"] -->|"promotes"| inflammation["inflammation"]
    STAT3["STAT3"] -->|"promotes"| inflammation["inflammation"]
    Artemisia_annua["Artemisia annua"] -.->|"inhibits"| inflammation["inflammation"]
    BECN1["BECN1"] -.->|"inhibits"| inflammation["inflammation"]
    NLRP3["NLRP3"] -->|"involved in"| inflammation["inflammation"]
    NLRP3_inflammasome_activation["NLRP3 inflammasome activation"] -->|"drives"| inflammation["inflammation"]
    RIPK1["RIPK1"] -->|"promotes"| inflammation["inflammation"]
    LUZP1["LUZP1"] -.->|"inhibits"| inflammation["inflammation"]
    hypothalamic_pituitary_adrenal["hypothalamic-pituitary-adrenal axis"] -->|"promotes"| inflammation["inflammation"]
    NLRP3["NLRP3"] -->|"promotes"| inflammation["inflammation"]
    PI3K_AKT_signaling_pathway["PI3K-AKT signaling pathway"] -->|"promotes"| inflammation["inflammation"]
    IL6_JAK_STAT3_pathway["IL6/JAK/STAT3 pathway"] -->|"causes"| inflammation["inflammation"]
    TNF__["TNF-α"] -->|"causes"| inflammation["inflammation"]
    ferritinophagy["ferritinophagy"] -->|"promotes"| inflammation["inflammation"]
    n116B["116B"] -.->|"suppresses"| inflammation["inflammation"]
    style TNF fill:#4fc3f7,stroke:#333,color:#000
    style inflammation fill:#4fc3f7,stroke:#333,color:#000
    style STAT3 fill:#4fc3f7,stroke:#333,color:#000
    style Artemisia_annua fill:#ff8a65,stroke:#333,color:#000
    style BECN1 fill:#ce93d8,stroke:#333,color:#000
    style NLRP3 fill:#4fc3f7,stroke:#333,color:#000
    style NLRP3_inflammasome_activation fill:#4fc3f7,stroke:#333,color:#000
    style RIPK1 fill:#4fc3f7,stroke:#333,color:#000
    style LUZP1 fill:#4fc3f7,stroke:#333,color:#000
    style hypothalamic_pituitary_adrenal fill:#81c784,stroke:#333,color:#000
    style PI3K_AKT_signaling_pathway fill:#81c784,stroke:#333,color:#000
    style IL6_JAK_STAT3_pathway fill:#81c784,stroke:#333,color:#000
    style TNF__ fill:#4fc3f7,stroke:#333,color:#000
    style ferritinophagy fill:#4fc3f7,stroke:#333,color:#000
    style n116B fill:#ff8a65,stroke:#333,color:#000